BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15292311)

  • 1. Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis.
    Storr HL; Isidori AM; Monson JP; Besser GM; Grossman AB; Savage MO
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3818-20. PubMed ID: 15292311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-related differences in the presentation and course of Cushing's disease.
    Pecori Giraldi F; Moro M; Cavagnini F;
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1554-8. PubMed ID: 12679438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.
    Dias R; Storr HL; Perry LA; Isidori AM; Grossman AB; Savage MO
    Horm Res; 2006; 65(3):159-62. PubMed ID: 16514243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How early can one diagnose Cushing's disease? An early diagnosis in a case of prepubertal Cushing's disease.
    Hoppmann J; Wagner IV; Junghans G; Wudy SA; Buchfelder M; Hirsch FW; Ritter L; Kiess W; Pfäffle R
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1043-7. PubMed ID: 25367688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis.
    Arnaldi G; Tirabassi G; Papa R; Furlani G; Trementino L; Cardinaletti M; Faloia E; Boscaro M
    Eur J Endocrinol; 2009 Jun; 160(6):891-8. PubMed ID: 19321661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test.
    Ritzel K; Beuschlein F; Berr C; Osswald A; Reisch N; Bidlingmaier M; Schneider H; Honegger J; Geyer LL; Schopohl J; Reincke M
    Eur J Endocrinol; 2015 Aug; 173(2):197-204. PubMed ID: 25953828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Martin NM; Dhillo WS; Banerjee A; Abdulali A; Jayasena CN; Donaldson M; Todd JF; Meeran K
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2582-6. PubMed ID: 16670165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.